Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2013
Regulation of microRNAs by epigenetics and their interplay involved in cancerXiaolan Liu, Xiaoyan Chen, Xinfang Yu, et al.
Cancer Gene Therapy|October 2, 2025
Demethoxycurcumin suppresses HK2-mediated glycolysis by targeting PTEN/Akt signalingJinzhuang Liao, Shiming Tan, Shuangze Han, et al.
Oncotarget|February 9, 2018
Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathwayMing Li, Xinfang Yu, Wei Li, et al.
Cell Death & Disease|December 19, 2022
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistanceMing Li, Feng Gao, Xiaoying Li, et al.
Frontiers in Oncology|August 18, 2023
AI-powered discovery of a novel p53-Y220C reactivatorShan Zhou, Dafei Chai, Xu Wang, et al.
Rice (New York, N.Y.)|July 16, 2025
Integrated Transcriptomic, Proteomic, and Metabolomic Analyses Reveal Mechanisms Underlying Day-Night Differences in Carbohydrate Metabolism between Diploid and Tetraploid RiceWeilong Meng, Yuchen Liu, Changjiang Zhang, et al.
Oncology Reports|June 6, 2015
The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review)Xiangjian Luo, Xinfang Yu, Sufang Liu, et al.
Cancer Letters|December 31, 2024
Vaccines targeting p53 mutants elicit anti-tumor immunityDafei Chai, Xu Wang, Chunmei Fan, et al.
Cancer Research|April 29, 2018
MYD88 L265P Mutation in Lymphoid MalignanciesXinfang Yu, Wei Li, Qipan Deng, et al.
Blood|November 22, 2024
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutationWei Li, Ruirui Wang, Junhao Wang, et al.
Pageof 6